(Q46909176)

English

Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-nations trial

scientific article published in February 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16433711

Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-nations trial (English)

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16433711

quality of life

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

R P L M Hoogma

1

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16433711

P J Hammond

2

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16433711

R Gomis

3

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16433711

D Kerr

4

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16433711

D Bruttomesso

5

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16433711

K P Bouter

6

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16433711

K J Wiefels

7

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16433711

H de la Calle

8

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16433711

D H Schweitzer

9

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16433711

M Pfohl

10

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16433711

E Torlone

11

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16433711

L G Krinelke

12

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16433711

G B Bolli

13

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16433711

5-Nations Study Group

14

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16433711

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 February 2006

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16433711

Diabetic Medicine

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16433711

23

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16433711

2

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16433711

141-147

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16433711

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01738.X

21 January 2018

Clinical evidence: glycaemic control in diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01738.X

21 January 2018

Continuous subcutaneous insulin infusion: a comprehensive review of insulin pump therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01738.X

21 January 2018

Insulin analogues and their potential in the management of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01738.X

21 January 2018

Less severe hypoglycaemia, better metabolic control, and improved quality of life in Type 1 diabetes mellitus with continuous subcutaneous insulin infusion (CSII) therapy; an observational study of 100 consecutive patients followed for a mean of 2 y

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01738.X

21 January 2018

Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with type 1 diabetes: a randomized open crossover trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01738.X

21 January 2018

Better long-term glycaemic control with the basal insulin glargine as compared with NPH in patients with Type 1 diabetes mellitus given meal-time lispro insulin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01738.X

21 January 2018

Continuous subcutaneous insulin infusion (CSII) in the Veneto region: efficacy, acceptability and quality of life

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01738.X

21 January 2018

Identifiers

10.1111/J.1464-5491.2005.01738.X

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16433711

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16433711

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46909176&oldid=2137579741"